GODISKA et al v. GRAY - Page 10




              Interference 104,002                                                                                             
              polynucleotide or amino acid sequence of the MN390 clone.  Estee Lauder v, L’Oreal,                              
              S.A., 129 F.3d at 592, 44 USPQ2d at 1613.                                                                        
                      We point out that Godiska states that                                                                    
                             Chemokines, also known as “intercines” and SIS cytokines,” comprise a                             
                      family of more than thirty small, secreted proteins (commonly 70-100 amino                               
                      acids in length and 8-10 kiloDaltons in size ...) that attract and activate                              
                      leukocytes (white blood cells) and thereby aid in the stimulation and regulation of                      
                      the immune system.  The name “chemokine” is derived from chemotactic                                     
                      cytokine, and refers to the ability of these proteins to stimulate chemotaxis                            
                      (movement) of leukocytes.  Indeed, chemokines as a group may comprise the                                
                      main attractants for inflammatory cells into pathological tissues.  The array of                         
                      activities of any individual chemokine (e.g., the types of white blood cells that the                    
                      chemokine attracts) generally is not identical to the array of activities of another                     
                      chemokine.  A chemokine may have attractant properties for more than one cell                            
                      type, and may have other activities in addition to its chemoattractant activities.                       
                      Conversely, a particular cell type may be influenced by more than one                                    
                      chemokine [emphasis added].  GB, pp. 47-48, Material Fact 106.                                           
                      Thus, Godiska acknowledges that identifying a novel polypeptide as being                                 
              structurally similar to other members of the chemokine family of compounds does not                              
              reveal its specific activity or utility.  Estee Lauder v, L’Oreal, S.A., 129 F.3d at 592,                        
              44 USPQ2d at 1613.  That is, it appears that chemokines may attract inflammatory                                 
              cells, but in any event the structure (amino acid composition) alone does not indicate                           
              which type of white blood cell it attracts.  Nor does the amino acid composition of the                          
              chemokine reveal anything about how it “stimulates and regulates” the immune system.                             
                      In our view, Godiska’s first recognition of a practical utility for the                                  
              polynucleotide/amino acid sequence of the MN390 clone occurred on March 3, 1995,                                 
              when Dr. Godiska received the report from Ms. Watson as to the differential in situ                              
              hybridization results.  GX 1013, p. 90; GX 1022, pp. 1-4; GR pp. 48-50, paras. 14-19.                            

                                                              10                                                               





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007